Profile for Croatia Patent: P20250157
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Croatia Patent: P20250157
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| 11,207,311 | Jul 28, 2037 | Janssen Biotech | AKEEGA | abiraterone acetate; niraparib tosylate |
| 11,986,468 | Jul 28, 2037 | Janssen Biotech | AKEEGA | abiraterone acetate; niraparib tosylate |
| 11,986,469 | Jul 28, 2037 | Janssen Biotech | AKEEGA | abiraterone acetate; niraparib tosylate |
| 11,986,470 | Jul 28, 2037 | Janssen Biotech | AKEEGA | abiraterone acetate; niraparib tosylate |
| 11,992,486 | Jul 28, 2037 | Janssen Biotech | AKEEGA | abiraterone acetate; niraparib tosylate |
| 12,383,543 | Jul 28, 2037 | Janssen Biotech | AKEEGA | abiraterone acetate; niraparib tosylate |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
